Myasthenia gravis: Difference between revisions

No edit summary
No edit summary
Line 1: Line 1:
==Background==
==Background==
*Due to autoantibody destruction of the nicotinic acetylcholine receptor at the NMJ
*Autoantibody degradation, dysfunction, and blockade of acetylcholine receptor at the NMJ
**Autoantiboides compete w/ acetycholine for these receptors
*Thymus is abnormal in 75% of pts
**Thymectomy resolves or improves symptoms in most pts, especially those with a thymoma
*No sensory, reflex, or cerebellar deficits
*Respiratory failure is feared complication
**Often precipitated by infection, surgery, or rapid tapering of immunosuppressive drugs
 
 
 
==Clinical Features==
#Symptoms worsen with repetitive use / as the day progresses
#Muscle weakness
##Proximal extremities
##Neck extensors
##Facial/bulbar muscles (dysphagia, dysarthria, dysphonia)
#Ocular weakness
##Ptosis
##Diplopia
##CN III, IV, or VI weakness


==DDX==
==DDX==
# Toxin Induced
#Lambert-Eaton Syndrome
##[[Botulism]]
#Drug-induced myasthenia (penicillamine, procainamide, quines, aminoglycosides)
##[[Tick Paralysis]]
#Botulism
## Envenomation (coral snake, black widow spider), paralytic shellfish
#Thyroid disorders
# Autoimmune - Lambert-Eaton Myasthenic syndrome
# Drug-Induced - aminoglycosides, dilantin, procainamide, chloroquine
# Poisoning - Organophosphates, Carbamates
# Miller Fisher Variant Guillen Barre
# Causes of oculomotor palsy - DM, MS, aneurysm
 
===Lambert-Eaton===
#rare, defect in release of AcH from presynapse
#Usually paraneoplastic (part. small cell Ca of lung)
# Clinically proximal weakness of limb muscles, hyporeflexia, dry mouth, impotence.
# Extraocular & facial muscles usually spared.


==Diagnosis==
==Management==
===History===
*Always evaluate tidal volume, FEV, ability to handle secretions
# pts report worse sxs as day progresses.
#Meds
# insidious onset, can develop over wks to months.
##Pyridostigmine
# precipitated by stress, preg, infec
###If pt's usual dose has been missed the next dose is usually doubled
###PO route: 60-90mg q4hr
###IV route: 1/30th of the PO dose (2-3mg) by slow IV infusion
##Neostigmine
###0.5mg IV
#Intubation
##If possible avoid depolarizing AND non-depolarizing agents
###If pt requires paralysis use non-depolarizing agent at smaller dose


===Symptoms===
# diplopia, ptosis (later in day)
# weakness in eye closure, swallowing muscles of facial expression, difficulty chewing, dysarthria, dysphagia.


===Physical Exam===
# Provocative tests - ptosis with prolonged upward gaze, hold arms up, clench tongue blade, dysarthria w/ loud counting
# sensation, reflexes usually normal
# always eval tidal volume, FEV & ability to handle secretions


===Testing===
===Testing===

Revision as of 05:29, 6 October 2011

Background

  • Autoantibody degradation, dysfunction, and blockade of acetylcholine receptor at the NMJ
  • Thymus is abnormal in 75% of pts
    • Thymectomy resolves or improves symptoms in most pts, especially those with a thymoma
  • No sensory, reflex, or cerebellar deficits
  • Respiratory failure is feared complication
    • Often precipitated by infection, surgery, or rapid tapering of immunosuppressive drugs


Clinical Features

  1. Symptoms worsen with repetitive use / as the day progresses
  2. Muscle weakness
    1. Proximal extremities
    2. Neck extensors
    3. Facial/bulbar muscles (dysphagia, dysarthria, dysphonia)
  3. Ocular weakness
    1. Ptosis
    2. Diplopia
    3. CN III, IV, or VI weakness

DDX

  1. Lambert-Eaton Syndrome
  2. Drug-induced myasthenia (penicillamine, procainamide, quines, aminoglycosides)
  3. Botulism
  4. Thyroid disorders

Management

  • Always evaluate tidal volume, FEV, ability to handle secretions
  1. Meds
    1. Pyridostigmine
      1. If pt's usual dose has been missed the next dose is usually doubled
      2. PO route: 60-90mg q4hr
      3. IV route: 1/30th of the PO dose (2-3mg) by slow IV infusion
    2. Neostigmine
      1. 0.5mg IV
  2. Intubation
    1. If possible avoid depolarizing AND non-depolarizing agents
      1. If pt requires paralysis use non-depolarizing agent at smaller dose


Testing

  1. Always test FEV, consider ABG, Look for infections (resp) or meds, electrolyte problems that may have induced problem.
  2. Edrophonium - use caution in trying to test for crisis vs. cholinergic crisis
  3. Ach receptor antibodies - found 90%
  4. CT of thymus, TFTs, search for other immun dz

Treatment

  1. Plasmapherisis or plasma exchenge in acute setting
  2. Anticholinesterase agent such as Pyridostigmine 60 mg tid
  3. Corticosteroids produce good results in >80% but are reserved for those who don't respond to anti-cholinesterases and thymectomy due to adverse effects. Decreases levels of antiAch receptor Ab. Also may initially aggravate muscle weakness so usually begun in hosp & at low doses
  1. don't treat Myasthenic with meds that may exacerbate weakness
  2. search for source of infection or electrolyte problem w/ weakness

Myasthenic Crisis vs. Cholinergic

  1. Cholinergic - usually present w/ signs of cholinergic overactivity (miosis, sweats, salivation, GI distress-musc) & cramps, fasciculations (nicotinic)
  2. Myasthenic - more common, caused by noncompliance, drug interaction, infection, stress
    1. aminoglycosides, flouroquinolones, clinda, sulfas, erythro, ampicillin, Dilantin, phenobarb, B blockers, Ca channel Blk, procainamide, steroids, lithium, phenothiazines, MSO4, benzos, antihistamines

VERY DANGEROUS & UNRELIABLE to use Tensilon Test to distinguish between the two.

Source

Harwood Nuss p.1002